Encana (NYSE:ECA) last posted its quarterly earnings results on Friday, July 25th. The company reported $0.25 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.27 by $0.02. Analysts expect that Encana will post $1.73 EPS for the current fiscal year. Encana Corporation (NYSE:ECA) in last trading activity advanced 0.48% to close at $18.72. Company weekly performance is -0.48% while its quarterly performance stands at -11.91%. Encana Corporation (NYSE:ECA) is -24.36% away from its 52 week high. Oppenheimer reiterated their buy rating on shares of Himax Technologies, Inc. (NASDAQ:HIMX) in a research note released on Oct. 10. They currently have a $12.00 target price on the stock, up from their previous target price of $8.50. Himax Technologies, Inc. (NASDAQ:HIMX) in last trading activity advanced 1.63% to close at $8.71. Company weekly performance is 4.44% while its quarterly performance stands at 43.73%. Himax Technologies, Inc. (NASDAQ:HIMX) is -43.66% away from its 52 week high. Fibrocell Science Inc. (NASDAQ:FCSC), a biopharmaceutical company based in Exton, Pa., said CFO Gregory Weaver is no longer with the company, effective Wednesday. Kimberly Smith, its controller who joined the company in January, will assume the role on an interim basis while the company searches for a permanent successor. Mr. Weaver joined Fibrocell in September 2013 and the company recently boosted his salary to $330,000 per year from $300,000, according to a regulatory filing. On last trading day Fibrocell Science, Inc. (NASDAQ:FCSC) advanced 1.01% to close at $3.00. Its volatility for the week is 7.99% while volatility for the month is 7.57%. FCSC's sales growth for past 5 years was -28.90% and its EPS growth for past 5 years was 43.20%. Fibrocell Science, Inc. (NASDAQ:FCSC) monthly performance is 0.67%. The Dow Chemical Company (NYSE:DOW) will be releasing its Q314 earnings data on Wednesday, October 22nd. Analysts expect The Dow Chemical Company to post earnings of $0.68 per share and revenue of $14.31 billion for the quarter. The Dow Chemical Company (NYSE:DOW) in last trading activity moved up 1.00% to close at $46.51. Company weekly performance is 3.61% while its quarterly performance stands at -10.45%. The Dow Chemical Company (NYSE:DOW) is -14.79% away from its 52 week high. Harte-Hanks Inc. (NYSE:HHS) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.12 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.10 by $0.02. The company had revenue of $140.30 million for the quarter, compared to the consensus estimate of $140.55 million. During the same quarter last year, the company posted $0.15 earnings per share. Harte-Hanks’s revenue was up .1% compared to the same quarter last year. On average, analysts predict that Harte-Hanks will post $0.48 earnings per share for the current fiscal year. On Monday shares of Harte-Hanks Inc. (NYSE:HHS) closed at $5.97. Company's sales growth for last 5 years was -12.40% and EPS growth for next 5 years is recorded as -4.80%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
